Dashboard
Manage Tickers

IOVA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 17:05:48

iovance-biotherapeutics-affirms-fy2025-sales-guidance-of-250000m-300000m-vs-264918m-est
Iovance Biotherapeutics Affirms FY2025 Sal...
11/06/2025 13:01:20

Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2025 sales outlook from $250.000 million-$300.000 million to $250.000 million-$...

iovance-biotherapeutics-q3-eps-025-beats-026-estimate-sales-67455m-miss-72402m-estimate
Iovance Biotherapeutics Q3 EPS $(0.25) Bea...
11/06/2025 13:00:57

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate ...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

examining-the-future-iovance-biotherapeuticss-earnings-outlook
Examining the Future: Iovance Biotherapeut...
11/05/2025 18:02:31

iovance-biotherapeutics-interim-data-from-phase-2-iov-lun-202-trial-of-lifileucel-monotherapy-for-previously-treated-patients-with-advanced-nonsquamous-nsclc-without-actionable-genetic-mutations-showed-26-objective-response-rate
Iovance Biotherapeutics' Interim Data From...
11/03/2025 12:03:33

The objective response rate (ORR) was 25.6% by RECIST v1.1 following one-time treatment with lifileucel monotherapy in patients...

hc-wainwright--co-maintains-buy-on-iovance-biotherapeutics-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on Iovan...
10/29/2025 17:38:18

HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the p...

keurig-dr-pepper-valneva-venu-holding-and-other-big-stocks-moving-lower-on-monday
Keurig Dr Pepper, Valneva, Venu Holding An...
08/25/2025 16:02:33

iovance-biotherapeutics--enters-amended-sale-agreement-with-jefferies-may-sell-up-to-350m-of-common-stock
Iovance Biotherapeutics Enters Amended Sa...
08/22/2025 21:23:44

-SEC Filing

intel-plymouth-industrial-reit-premier-and-other-big-stocks-moving-higher-on-tuesday
Intel, Plymouth Industrial REIT, Premier A...
08/19/2025 15:00:01

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 12:08:33

why-palo-alto-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Palo Alto Shares Are Trading Higher By...
08/19/2025 12:01:09

hc-wainwright--co-reiterates-buy-on-iovance-biotherapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Iova...
08/19/2025 11:06:56

HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $...

iovance-biotherapeutics-receives-health-canada-nocc-for-amtagvi
Iovance Biotherapeutics Receives Health Ca...
08/18/2025 20:24:10

First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD...

what-7-analyst-ratings-have-to-say-about-iovance-biotherapeutics
What 7 Analyst Ratings Have To Say About I...
08/08/2025 18:01:05

wells-fargo-maintains-overweight-on-iovance-biotherapeutics-lowers-price-target-to-14
Wells Fargo Maintains Overweight on Iovanc...
08/08/2025 15:30:29

Wells Fargo analyst Yanan Zhu maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and lowers the price target ...

pinterest-posts-downbeat-q2-earnings-joins-twilio-trade-desk-and-other-big-stocks-moving-lower-in-friday-pre-market-session
Pinterest Posts Downbeat Q2 Earnings, Join...
08/08/2025 12:43:36

chardan-capital-maintains-buy-on-iovance-biotherapeutics-lowers-price-target-to-20
Chardan Capital Maintains Buy on Iovance B...
08/08/2025 12:15:00

Chardan Capital analyst Geulah Livshits maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the price targ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

iovance-biotherapeutics-declines-29-in-premarket-trading-heres-whats-happening
Iovance Biotherapeutics Declines 29% In Pr...
08/08/2025 09:28:07

Iovance stock fell over 29% pre-market after Q2 results, despite reporting a strong revenue jump led by Amtagvi sales.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION